Eurlex法规编号：	(EU) 2017/841 Corr.
OJ编号：	OJ L 2, 5.1.2018, p. 14–14
中文标题：	对2017年5月17日委员会实施条例(EU) 2017/841的勘误：对关于延长活性物质甲-氯氰菊酯、氨甲酰、苯甲酰基、苯甲氧基、苯甲氧基、溴氧尼、卡芬特拉唑、氯苯酞酸、氯硝唑、异氰酸酯、苯甲氧嘧啶、苯甲氧嘧啶、苯甲砜、氟咪嗪、氟咪嗪、氟咪嗪、氟咪嗪、氟咪嗪、甲磺酰亚胺、氟咪嗪、甲氧苄嗪、咪唑啉、甲氧基溴铵、甲氧苄胺、甲氧基溴铵、苯甲醚、甲氧基苯磺酸、甲氧苄嗪、甲氧基苯胺、甲氧基苯胺、甲氧基苯胺、甲基异丙嗪、三甲氧基苯批准期限的(EU) No 540/2011号实施条例进行修订
原文标题：	Corrigendum to Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin ( OJ L 125, 18.5.2017 )
发布日期	2018-01-05
原文链接	查看欧盟官网文件